Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11060-020-03657-8.pdf
Reference39 articles.
1. Bast RC (2016) Holland-Frei cancer medicine, 9th edn. John Wiley & Sons Inc, Hoboken
2. Boire A, Brastianos PK, Garzia L, Valiente M (2020) Brain metastasis. Nat Rev Cancer 20:4–11. https://doi.org/10.1038/s41568-019-0220-y
3. Valiente M, Ahluwalia MS, Boire A et al (2018) The evolving landscape of brain metastasis. Trends Cancer 4:176–196. https://doi.org/10.1016/j.trecan.2018.01.003
4. Mulvenna P, Nankivell M, Barton R et al (2016) Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet 388:2004–2014. https://doi.org/10.1016/S0140-6736(16)30825-X
5. Lu-Emerson C, Eichler AF (2012) Brain metastases. Continuum (Minneap Minn) 18:295–311. https://doi.org/10.1212/01.CON.0000413659.12304.a6
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Canadian Breast Cancer Symposium 2023 Meeting Report;Current Oncology;2024-03-29
2. Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series;Journal of Neuro-Oncology;2023-06
3. Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series;2023-04-26
4. Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors—retrospective study;Radiation Oncology;2023-02-07
5. Patterns of Care and Survival in Cancer Patients with Brain Metastases Receiving Immune Checkpoint Inhibitors;Oncology Research and Treatment;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3